Severe fatigue after kidney transplantation: A highly prevalent, disabling and multifactorial symptom

Transplant International

Volumn 26, Issue 10, 2013, Pages 1007-1015

  Goedendorp, Martine M ^a,b   Hoitsma, Andries J ^a   Bloot, Lotte ^a   Bleijenberg, Gijs ^a   Knoop, Hans ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

creatinine; fatigue; functional impairments; kidney transplant recipients; proteinuria; psychosocial factors

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; FUNCTIONAL DISEASE; GRAFT RECIPIENT; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANT RECIPIENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

CREATININE; FATIGUE; FUNCTIONAL IMPAIRMENTS; KIDNEY TRANSPLANT RECIPIENTS; PROTEINURIA; PSYCHOSOCIAL FACTORS;

ADULT; AGED; BODY MASS INDEX; CREATININE; DEPRESSION; DISABLED PERSONS; FATIGUE; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREVALENCE; PROTEINURIA; PSYCHOLOGY; QUESTIONNAIRES; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 84884821504     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12166     Document Type: Article

References (50)

1. Murtagh FE, Addington-Hall J, Higginson IJ,. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007; 14: 82.
2. Weisbord SD, Fried LF, Arnold RM, et al,. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005; 16: 2487.
3. Jhamb M, Weisbord SD, Steel JL, Unruh M,. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis 2008; 52: 353.
4. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK,. Patient preferences for in-center intense hemodialysis. Hemodial Int 2005; 9: 281.
5. Kovacs AZ, Molnar MZ, Szeifert L, et al,. Sleep disorders, depressive symptoms and health-related quality of life-a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant 2011; 26: 1058.
6. Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M,. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant 2011; 25: E13.
7. Neipp M, Karavul B, Jackobs S, et al,. Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation 2006; 81: 1640.
8. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A,. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc 2011; 43: 376.
9. Donovan KA, Jacobsen PB, Small BJ, Munster PN, Andrykowski MA,. Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage 2008; 36: 480.
10. Russ G, Jamieson N, Oberbauer R, et al,. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine. Transpl Int 2007; 20: 875.
11. Trojan DA, Arnold D, Collet JP, et al,. Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler 2007; 13: 985.
12. Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JM, Wiegman O,. Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Br J Rheumatol 1998; 37: 1042.
13. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB,. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 2005; 32: 1699.
14. Tack BB,. Fatigue in rheumatoid arthritis. Conditions, strategies, and consequences. Arthritis Care Res 1990; 3: 65.
15. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G,. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007; 62: 571.
16. Voermans NC, Knoop H, van de Kamp N, Hamel BC, Bleijenberg G, van Engelen BG,. Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos Syndrome. Semin Arthritis Rheum 2010; 40: 267.
17. Goedendorp MM, Gielissen MF, Verhagen CA, Peters ME, Bleijenberg G,. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer 2008; 99: 1408.
18. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G,. Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J Pain Symptom Manage 2013; 45: 213.
19. Karakoc T, Yurtsever S,. Relationship between social support and fatigue in geriatric patients receiving outpatient chemotherapy. Eur J Oncol Nurs 2010; 14: 61.
20. Li Y, Yuan C,. Levels of fatigue in Chinese women with breast cancer and its correlates: a cross-sectional questionnaire survey. J Am Acad Nurse Pract 2011; 23: 153.
21. Michael KM, Allen JK, Macko RF,. Fatigue after stroke: relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy. Rehabil Nurs 2006; 31: 210.
22. CentERdata. CentErdata Institute for data collection and research. www.centerdata.nl (last accessed 6 August 2012).
23. Dittner AJ, Wessely SC, Brown RG,. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157.
24. Vercoulen JHMM, Alberts M, Bleijenberg G,. De Checklist Individual Strength (CIS). Gedragstherapie 1999; 32: 131.
25. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G,. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 383.
26. Minis MA, Kalkman JS, Akkermans RP, et al,. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis. J Rehabil Med 2010; 42: 60.
27. Snaphaan L, van der Werf S, de Leeuw FE,. Time course and risk factors of post-stroke fatigue: a prospective cohort study. Eur J Neurol 2011; 18: 611.
28. van Hoogmoed D, Fransen J, Repping-Wuts H, Spee L, Bleijenberg G, van Riel PL,. The effect of anti-TNF-alpha vs. DMARDs on fatigue in rheumatoid arthritis patients. Scand J Rheumatol 2013; 42: 15.
29. Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM,. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012; 379: 1412.
30. Bergner M, Bobbitt RA, Carter WB, Gilson BS,. The Sickness Impact Profile-development and final revision of a health-status measure. Med Care 1981; 19: 787.
31. Jacobs HM, Luttik A, Fouw OF, de Melker RA,. De 'sickness impact profile; resultaten van een valideringsonderzoek van de Nederlandse versie [The sickness impact profile; results of an evaluation study of the Dutch version]. Ned Tijdschr Geneeskd 1990; 134: 1950.
32. Aaronson NK, Muller M, Cohen PD, et al,. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055.
33. Beck AT, Steer RA, Ball R, Ciervo CA, Kabat M,. Use of the Beck Anxiety and Depression Inventories for Primary Care with medical outpatients. Assessment 1997; 4: 211.
34. Beck AT, Guth D, Steer RA, Ball R,. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997; 35.
35. Beck AT, Steer RA, Brown GK,. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
36. van Sonderen E,. Sociale Steun Lijst-Interacties (SSL-I) en Sociale Steun Lijst-Discrepanties (SSL-D): Een handleiding. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1993.
37. Cohen J,. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988.
38. Cohen J,. A power primer. Psychol Bull 1992; 112: 155.
39. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
40. de Groot IB, Stiggelbout AM, van der Boog PJ, Baranski AG, Marang-van de Mheen PJ, group PA-s. Reduced quality of life in living kidney donors: association with fatigue, societal participation and pre-donation variables. Transpl Int 2012; 25: 967.
41. Blokstra A, Vissink P, Venmans LMAJ, Holleman P, van der Schouw YT, Smit HA,. Nederland de Maat Genomen, 2009-2010. Monitoring van risicofactoren in de algemene bevolking. RIVM-rapport nr. 260152001/2011, Bildhoven, 2011.
42. Forsberg A, Lorenzon U, Nilsson F, Backmana L,. Pain and health related quality of life after heart, kidney, and liver transplantation. Clin Transplant 1999; 13: 453.
43. Perez-San-Gregorio MA, Martin-Rodriguez A, Perez-Bernal J,. Influence of the psychological state of relatives on the quality of life of patients at 1 year after transplantation. Transplant Proc 2008; 40: 3109.
44. White C, Gallagher P,. Effect of patient coping preferences on quality of life following renal transplantation. J Adv Nurs 2010; 66: 2550.
45. Griva K, Stygall J, Ng JH, Davenport A, Harrison MJ, Newman S,. Prospective changes in health-related quality of life and emotional outcomes in kidney transplantation over 6 years. J Transplant 2011; Article ID: 671571. doi: 10.1155/2011/671571.
46. Gielissen MF, Verhagen S, Witjes F, Bleijenberg G,. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006; 24: 4882.
47. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G,. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001; 286: 1360.
48. Gielissen MFM,. Cognitive behaviour therapy for postcancer fatigue: a treatment protocol. In: Fatigue in Cancer Survivors: From Assessment to Cognitive Behavior Therapy. Wageningen: Ponsen & Looijen B.V., 2007: 36-49.
49. Vercoulen JH, Swanink CM, Galama JM, et al,. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507.
50. Goedendorp MM, Peters ME, Gielissen MF, et al,. Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist 2010; 15: 1122.